Trials / Completed
CompletedNCT00134368
Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo
Pilot, Investigator-Initiated, Proof-of-Concept, Study of the Efficacy and Safety of Etanercept (Enbrel) in Adults With Vitiligo
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (planned)
- Sponsor
- University of Medicine and Dentistry of New Jersey · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the efficacy and safety of etanercept in adults with vitiligo.
Detailed description
Subjects will self-administer etanercept 50 mg SQ twice weekly for 6 months. Lesion repigmentation will be evaluated at monthly visits.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Etanercept |
Timeline
- Start date
- 2003-11-01
- Completion
- 2007-12-01
- First posted
- 2005-08-24
- Last updated
- 2008-08-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00134368. Inclusion in this directory is not an endorsement.